Telmisartan placebo

DRUG2 trials

Sponsors

Yuhan Corporation, Boehringer Ingelheim

Conditions

HealthyHyperlipidemiaHypertension

Phase 1

Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy Subjects

CompletedNCT02187536

Boehringer IngelheimHealthy

Start: 2000-04-30Updated: 2014-07-11

Phase 3

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

CompletedNCT01914432

Yuhan CorporationHyperlipidemia, Hypertension

Start: 2013-11-30End: 2014-06-30Updated: 2014-07-08

Related Papers

Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study.

2018-04-1722 citations